{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:41:30Z","timestamp":1790628090144,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112042","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T01:26:20Z","timestamp":1628904380000},"page":"112042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Immunomodulation effect of mesenchymal stem cells in islet transplantation"],"prefix":"10.1016","volume":"142","author":[{"given":"Manju","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiep Tien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Uk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"issue":"Pt 11","key":"10.1016\/j.biopha.2021.112042_bib2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2021.112042_bib3","doi-asserted-by":"crossref","unstructured":"A. Tyndall, U.A. Walker, A. Cope, et al. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis research & therapy, 2007;9(1):301.","DOI":"10.1186\/ar2103"},{"issue":"11","key":"10.1016\/j.biopha.2021.112042_bib4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","article-title":"Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy","volume":"12","author":"Cipriani","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2021.112042_bib6","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","article-title":"Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression","volume":"27","author":"Ren","year":"2009","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","article-title":"T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression","volume":"12","author":"Klyushnenkova","year":"2005","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.trre.2008.05.002","article-title":"Role of mesenchymal stromal cells in solid organ transplantation","volume":"22","author":"Hematti","year":"2008","journal-title":"Transplant. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2021.112042_bib10","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1111\/j.1600-6143.2006.01541.x","article-title":"Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets","volume":"6","author":"Miao","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib11","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.179.5.2824","article-title":"The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells","volume":"179","author":"Jones","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112042_bib12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcyt.2013.02.010","article-title":"Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal","volume":"15","author":"Krampera","year":"2013","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"14","key":"10.1016\/j.biopha.2021.112042_bib14","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","article-title":"Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy","volume":"77","author":"Fan","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib15","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/cddiscovery.2015.7","article-title":"Rap1-mediated nuclear factor-kappaB (NF-\u03baB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction","volume":"1","author":"Zhang","year":"2015","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41419-018-0414-3","article-title":"Rap1 deficiency-provoked paracrine dysfunction impairs immunosuppressive potency of mesenchymal stem cells in allograft rejection of heart transplantation","volume":"9","author":"Ding","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.stemcr.2016.02.006","article-title":"Inhibition of IKK\/NF-\u03baB signaling enhances differentiation of mesenchymal stromal cells from human embryonic stem cells","volume":"6","author":"Deng","year":"2016","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib18","doi-asserted-by":"crossref","first-page":"56924","DOI":"10.1371\/journal.pone.0056924","article-title":"Inhibition of nuclear factor-\u03baB activation in pancreatic \u03b2-cells has a protective effect on allogeneic pancreatic islet graft survival","volume":"8","author":"Eldor","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trre.2012.11.003","article-title":"Potential role of mesenchymal stromal cells in pancreatic islet transplantation","volume":"27","author":"Hematti","year":"2013","journal-title":"Transplant. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jcyt.2012.11.008","article-title":"Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice","volume":"15","author":"Rackham","year":"2013","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.biopha.2021.112042_bib21","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/stem.2372","article-title":"Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models of ARDS","volume":"34","author":"Jackson","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2021.112042_bib22","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3389\/fimmu.2018.01658","article-title":"Critical role of tumor necrosis factor signaling in mesenchymal stem cell-based therapy for autoimmune and inflammatory diseases","volume":"9","author":"Yan","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/stem.3134","article-title":"Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer","volume":"38","author":"Rackham","year":"2020","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12929-018-0429-1","article-title":"Regenerative abilities of mesenchymal stem cells through mitochondrial transfer","volume":"25","author":"Paliwal","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2021.112042_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcell.2016.00107","article-title":"Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer","volume":"4","author":"Torralba","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s00125-013-3109-4","article-title":"Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model","volume":"57","author":"Borg","year":"2014","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib27","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/db16-1068","article-title":"Cotransplantation of mesenchymal stem cells with neonatal porcine islets improve graft function in diabetic mice","volume":"66","author":"Hayward","year":"2017","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.biopha.2021.112042_bib28","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/TP.0b013e3181db09c4","article-title":"Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function","volume":"89","author":"Ito","year":"2010","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.0900803","article-title":"Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes","volume":"183","author":"Fiorina","year":"2009","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib30","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib31","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/eji.200425405","article-title":"Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway","volume":"35","author":"Augello","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression","volume":"35","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.biopha.2021.112042_bib33","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2337\/db10-0542","article-title":"Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes","volume":"59","author":"Jurewicz","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib34","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/db08-0180","article-title":"Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes","volume":"57","author":"Abdi","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","article-title":"Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells","volume":"26","author":"Selmani","year":"2008","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib36","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.2337\/db11-0844","article-title":"Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes","volume":"61","author":"Bassi","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2010.04178.x","article-title":"Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells","volume":"161","author":"Li","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2021.112042_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4107943","article-title":"Cotransplantation of mesenchymal stem cells and immature dendritic cells potentiates the blood glucose control of islet allografts","volume":"2017","author":"Long","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib39","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00592-015-0735-y","article-title":"Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site","volume":"52","author":"Ben Nasr","year":"2015","journal-title":"Acta Diabetol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112042_bib40","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.biopha.2021.112042_bib41","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.4049\/jimmunol.176.9.5255","article-title":"Interleukin-2-dependent mechanisms of tolerance and immunity in vivo","volume":"176","author":"Antony","year":"2006","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib42","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib43","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biopha.2021.112042_bib44","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3727\/096368910X508762","article-title":"Mesenchymal stem cells: mechanisms of immunomodulation and homing","volume":"19","author":"Yagi","year":"2010","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2021.112042_bib46","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.yexcr.2010.08.008","article-title":"Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells","volume":"316","author":"Ya\u00f1ez","year":"2010","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib47","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1002\/eji.201141499","article-title":"Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor","volume":"41","author":"Duffy","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213170","article-title":"Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress","volume":"14","author":"Laing","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1182\/blood-2006-02-002246","article-title":"Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells","volume":"109","author":"Sato","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biopha.2021.112042_bib50","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/db09-0317","article-title":"Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9","volume":"58","author":"Ding","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4110\/in.2015.15.5.241","article-title":"Galectin-9 is involved in immunosuppression mediated by human bone marrow-derived clonal mesenchymal stem cells","volume":"15","author":"Kim","year":"2015","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib52","doi-asserted-by":"crossref","first-page":"12712","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.biopha.2021.112042_bib53","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3389\/fimmu.2020.01076","article-title":"Immunosuppressive property of MSCs mediated by cell surface receptors","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3083.2010.02491.x","article-title":"New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins","volume":"73","author":"Sioud","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.biopha.2021.112042_bib55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3389\/fimmu.2019.01288","article-title":"Immunomodulatory effect of MSC on B cells is independent of secreted extracellular vesicles","volume":"10","author":"Carreras-Planella","year":"2019","journal-title":"Front Immunol."},{"issue":"1843","key":"10.1016\/j.biopha.2021.112042_bib56","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3389\/fimmu.2020.01843","article-title":"The immunomodulatory effects of mesenchymal stem cells on regulatory B cells","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/dna.2005.24.458","article-title":"Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice","volume":"24","author":"Deng","year":"2005","journal-title":"DNA Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib59","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2016.07.006","article-title":"Role of regulatory B cells in immune tolerance to allergens and beyond","volume":"138","author":"van de Veen","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib60","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1900\/RDS.2010.7.132","article-title":"Mesenchymal stem cells as feeder cells for pancreatic islet transplants","volume":"7","author":"Sordi","year":"2010","journal-title":"Rev. Diabet. Stud."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2008.10.004","article-title":"Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia","volume":"32","author":"Boumaza","year":"2009","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.biopha.2021.112042_bib62","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib63","first-page":"516","article-title":"Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory\/suppressive phenotype","volume":"90","author":"Maccario","year":"2005","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib64","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2021.112042_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2016.04.008","article-title":"Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation","volume":"37","author":"Michelo","year":"2016","journal-title":"Transpl. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib67","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12079-018-0448-4","article-title":"Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation","volume":"12","author":"Najar","year":"2018","journal-title":"J. Cell Commun. Signal."},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib68","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1002\/jcp.26305","article-title":"Immunomodulatory effects of foreskin mesenchymal stromal cells on natural killer cells","volume":"233","author":"Najar","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/14653249.2010.523077","article-title":"Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways","volume":"13","author":"G\u00f6therstr\u00f6m","year":"2011","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.biopha.2021.112042_bib70","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib71","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.177.4.2080","article-title":"Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells","volume":"177","author":"Nauta","year":"2006","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib72","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.biopha.2021.112042_bib73","first-page":"1366","article-title":"Granulocyte\/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival","volume":"60","author":"Rastellini","year":"1995","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2249.2010.04157.x","article-title":"The immunotherapeutic potential of dendritic cells in type 1 diabetes","volume":"161","author":"Mukherjee","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112042_bib75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dia.2009.0154","article-title":"Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation","volume":"12","author":"Longoni","year":"2010","journal-title":"Diabetes Technol. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2021.112042_bib76","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/stem.217","article-title":"Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells","volume":"27","author":"Zangi","year":"2009","journal-title":"Stem Cells"},{"issue":"13","key":"10.1016\/j.biopha.2021.112042_bib77","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib78","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib79","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbrc.2018.10.070","article-title":"Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cells","volume":"506","author":"Duan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib80","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00125-011-2433-9","article-title":"Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice","volume":"55","author":"Xu","year":"2012","journal-title":"Diabetologia"},{"issue":"15","key":"10.1016\/j.biopha.2021.112042_bib81","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1089\/scd.2014.0488","article-title":"iPSC-MSCs combined with low-dose rapamycin induced islet allograft tolerance through suppressing Th1 and enhancing regulatory T-cell differentiation","volume":"24","author":"Cheng","year":"2015","journal-title":"Stem Cells Dev."},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2119\/molmed.2010.00098","article-title":"Interleukin (IL)-10 induced by CD11b+ cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts","volume":"17","author":"Kim","year":"2011","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib83","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.2337\/db10-0136","article-title":"Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates","volume":"59","author":"Berman","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib84","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2009.01.003","article-title":"Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia","volume":"32","author":"Solari","year":"2009","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib85","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","article-title":"Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells","volume":"52","author":"Madec","year":"2009","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.biopha.2021.112042_bib86","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/TP.0b013e3181cb3e8d","article-title":"Bone marrow cell cotransplantation with islets improves their vascularization and function","volume":"89","author":"Sakata","year":"2010","journal-title":"Transplantation"},{"issue":"5\u20136","key":"10.1016\/j.biopha.2021.112042_bib87","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1089\/ten.tea.2014.0022","article-title":"Transplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis","volume":"21","author":"Shin","year":"2015","journal-title":"Tissue Eng. Part A"},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib88","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00007890-199908150-00012","article-title":"Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation","volume":"68","author":"Drachenberg","year":"1999","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.biopha.2021.112042_bib89","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2337\/db06-0173","article-title":"Sirolimus is associated with reduced islet engraftment and impaired beta-cell function","volume":"55","author":"Zhang","year":"2006","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib90","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.4049\/jimmunol.170.10.4996","article-title":"Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene","volume":"170","author":"Silva","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1432-2277.2008.00743.x","article-title":"Rapamycin in islet transplantation: friend or foe?","volume":"22","author":"Berney","year":"2009","journal-title":"Transpl. Int."},{"key":"10.1016\/j.biopha.2021.112042_bib92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2011.09.003","article-title":"In vitro morphogenesis of PANC-1 cells into islet-like aggregates using RGD-covered dextran derivative surfaces","volume":"89","author":"Dubiel","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib93","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1021\/acsbiomaterials.9b00570","article-title":"Sensitivity study for the key parameters in heterospheroid preparation with insulin-secreting \u03b2-cells and mesenchymal stem cells","volume":"5","author":"Bal","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biopha.2021.112042_bib94","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1186\/s12885-015-2025-z","article-title":"Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation","volume":"15","author":"Grange","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2021.112042_bib95","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2018.02538","article-title":"Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function","volume":"9","author":"Reis","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112042_bib96","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1002\/jcb.27260","article-title":"Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes","volume":"119","author":"Nojehdehi","year":"2018","journal-title":"J. Cell Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib97","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s12026-016-8798-6","article-title":"Immunomodulatory effects of mesenchymal stromal cells-derived exosome","volume":"64","author":"Chen","year":"2016","journal-title":"Immunol. Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.112042_bib98","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.3727\/096368915X687543","article-title":"Immunoregulatory effects of mesenchymal stem cell-derived extracellular vesicles on T lymphocytes","volume":"24","author":"Del Fattore","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.biopha.2021.112042_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2020.00013","article-title":"Immunoregulatory effects of stem cell-derived extracellular vesicles on immune cells","volume":"11","author":"Xie","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3727\/096368911X582769b","article-title":"The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles","volume":"22","author":"Budoni","year":"2013","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib101","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/JME-17-0080","article-title":"Stem cell-derived exosomes: a novel vector for tissue repair and diabetic therapy","volume":"59","author":"Newton","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.biopha.2021.112042_bib102","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2021.112042_bib103","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2337\/db14-0295","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis","volume":"63","author":"D\u2019Addio","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2021.112042_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5500\/wjt.v1.i1.13","article-title":"Recent progress in pancreatic islet transplantation","volume":"1","author":"Kuise","year":"2011","journal-title":"World J. Transplant."},{"key":"10.1016\/j.biopha.2021.112042_bib105","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3727\/096368911X627534","article-title":"Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets","volume":"21","author":"Cantaluppi","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.biopha.2021.112042_bib106","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/bmt.2010.278","article-title":"Human BM stem cells initiate angiogenesis in human islets in vitro","volume":"46","author":"Luo","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.biopha.2021.112042_bib107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biomaterials.2014.10.060","article-title":"Improved islet transplantation outcome by the co-delivery of siRNAs for iNOS and 17\u03b2-estradiol using an R3V6 peptide carrier","volume":"38","author":"Hwang","year":"2015","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib108","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.2337\/db13-1431","article-title":"Maternal protein restriction leads to pancreatic failure in offspring: role of misexpressed microRNA-375","volume":"63","author":"Dumortier","year":"2014","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.biopha.2021.112042_bib109","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1021\/mp800093f","article-title":"Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human islets","volume":"5","author":"Cheng","year":"2008","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nbt.1830","article-title":"SiRNA delivery with exosome nanoparticles","volume":"29","author":"van den Boorn","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2021.112042_bib111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/TP.0b013e3181c7dc99","article-title":"Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation","volume":"89","author":"Park","year":"2010","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib113","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bbrc.2007.09.061","article-title":"Vascular endothelial growth factor (VEGF) suppresses ovarian granulosa cell apoptosis in vitro","volume":"363","author":"Kosaka","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2021.112042_bib114","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1096\/fj.201700061RR","article-title":"Interleukin 6 protects pancreatic \u03b2 cells from apoptosis by stimulation of autophagy","volume":"31","author":"Linnemann","year":"2017","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.biopha.2021.112042_bib115","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2337\/db17-1280","article-title":"Interleukin-6 reduces \u03b2-cell oxidative stress by linking autophagy with the antioxidant response","volume":"67","author":"Marasco","year":"2018","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib116","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1189\/jlb.1104649","article-title":"Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts","volume":"77","author":"Barshes","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib117","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbrc.2007.07.105","article-title":"Allogeneic bone marrow supports human islet beta cell survival and function over six months","volume":"361","author":"Luo","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib118","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/19382014.2017.1286434","article-title":"Effect of co-culture of mesenchymal stem\/stromal cells with pancreatic islets on viability and function outcomes: a systematic review and meta-analysis","volume":"9","author":"de Souza","year":"2017","journal-title":"Islets"},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib119","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib120","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3390\/ijms14012119","article-title":"Low oxygen tension maintains multipotency, whereas normoxia increases differentiation of mouse bone marrow stromal cells","volume":"14","author":"Berniakovich","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib121","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4110\/in.2013.13.4.133","article-title":"Mesenchymal stem cell lines isolated by different isolation methods show variations in the regulation of graft-versus-host disease","volume":"13","author":"Yoo","year":"2013","journal-title":"Immune Netw."},{"issue":"3","key":"10.1016\/j.biopha.2021.112042_bib122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biologicals.2014.01.003","article-title":"Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment","volume":"42","author":"Holubova","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.biopha.2021.112042_bib123","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-319-45457-3_7","article-title":"Cryopreserved or fresh mesenchymal stromal cells: only a matter of taste or key to unleash the full clinical potential of MSC therapy?","volume":"951","author":"Moll","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib124","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41551-018-0325-8","article-title":"Manufacturing of primed mesenchymal stromal cells for therapy","volume":"3","author":"Yin","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"5","key":"10.1016\/j.biopha.2021.112042_bib125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/scrt336","article-title":"Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells","volume":"4","author":"Ribeiro","year":"2013","journal-title":"Stem Cell Res. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2021.112042_bib126","first-page":"845","article-title":"Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential","volume":"88","author":"in \u2019t Anker","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2021.112042_bib127","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3389\/fimmu.2017.01042","article-title":"Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function","volume":"8","author":"Luk","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/erc.13.5","article-title":"Perspective and challenges of mesenchymal stem cells for cardiovascular regeneration","volume":"11","author":"Zhang","year":"2013","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.biopha.2021.112042_bib129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4939-3584-0_17","article-title":"Directed differentiation of human-induced pluripotent stem cells to mesenchymal stem cells","volume":"1416","author":"Lian","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1634\/stemcells.2006-0420","article-title":"Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs","volume":"25","author":"Lian","year":"2007","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.biopha.2021.112042_bib131","doi-asserted-by":"crossref","first-page":"C115","DOI":"10.1152\/ajpcell.00326.2011","article-title":"Regulation of cell proliferation of human induced pluripotent stem cell-derived mesenchymal stem cells via ether-\u00e0-go-go 1 (hEAG1) potassium channel","volume":"303","author":"Zhang","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112042_bib132","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41591-020-1050-x","article-title":"Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study","volume":"26","author":"Bloor","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.112042_bib133","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/cells8050403","article-title":"Current challenges of iPSC-based disease modeling and therapeutic implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2021.112042_bib134","first-page":"125","article-title":"Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives","volume":"8","author":"Zomer","year":"2015","journal-title":"Stem Cells Cloning Adv. Appl."},{"key":"10.1016\/j.biopha.2021.112042_bib135","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6726185","article-title":"Current strategies to generate human mesenchymal stem cells in vitro","volume":"2018","author":"Steens","year":"2018","journal-title":"Stem Cells Int."},{"issue":"10","key":"10.1016\/j.biopha.2021.112042_bib136","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41419-019-1957-7","article-title":"Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-\u03b1-stimulated gene-6 in inflammatory bowel disease models","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1954","key":"10.1016\/j.biopha.2021.112042_bib137","article-title":"Mesenchymal stem cell\u2013derived exosomes: a promising biological tool in nanomedicine","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5966\/sctm.2016-0038","article-title":"Exosomes derived from akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D","volume":"6","author":"Ma","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"7","key":"10.1016\/j.biopha.2021.112042_bib139","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/stem.1771","article-title":"HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing","volume":"33","author":"Zhang","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2021.112042_bib140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphys.2016.00024","article-title":"Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis","volume":"7","author":"Merino-Gonz\u00e1lez","year":"2016","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib141","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12967-015-0642-6","article-title":"LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b","volume":"13","author":"Ti","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2021.112042_bib142","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/jcm8071025","article-title":"The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity","volume":"8","author":"Zhou","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib143","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1609206","article-title":"Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications","volume":"8","author":"Witwer","year":"2019","journal-title":"J. Extracell. Vesicles"},{"issue":"4","key":"10.1016\/j.biopha.2021.112042_bib144","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","article-title":"New technologies for analysis of extracellular vesicles","volume":"118","author":"Shao","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2021.112042_bib145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2021.112042_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-017-0160-y","article-title":"Preservation and storage stability of extracellular vesicles for therapeutic applications","volume":"20","author":"Jeyaram","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2021.112042_bib147","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2019.1593755","article-title":"Clinical requirements for extracellular vesicle assays","volume":"8","author":"Ayers","year":"2019","journal-title":"J. Extracell. Vesicles"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:34:23Z","timestamp":1760099663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221008258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":147,"alternative-id":["S0753332221008258"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112042","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation effect of mesenchymal stem cells in islet transplantation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112042"}}